| abstract |
1. The use of the peptide Val-Pro-Ile-Gln-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val-Thr-Arg-Ile-Asn-Asp- Ile-Ser-His-Thr-Gln-Ser-Val-Ser-Ser-Lys-Gln-Lys-OH and its salts and hydrates to obtain a pharmaceutical composition for the treatment and / or prevention of malignant tumors, autoimmune diseases, fibrosis, inflammatory diseases , neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases, and metabolic diseases. ! 2. The use of the peptide according to claim 1, where the infectious disease is a bacterial, fungal or viral infectious disease that is selected from alveolar hydatide disease (AHD, echinococcosis), amoebiasis (Entamoeba histolyca infection), Angiostrongylus invasion, anisakiase, anthrax, babesiosis (Babesia infections), Balantidum infections (balantidiasis), Blastocystis hominis infections (blastomycosis), borreliosis, botulism, Brainer’s diarrhea, brucellosis, candidiasis, capillariosis (Capillaria invasion), chronic fatigue syndrome (CFS), Chagas disease (American trypanosomiasis), chickenpox (chickenpox virus), Chlamydia pneumoniae infection, cholera, Creutzfeldt-Jakob disease (CJD), clonorchosis (Clonorchis invasion), migratory cutaneous larvae (CLM) (nematode invasion), coccidiocidiosis, viral infection (diseases of the hands, feet, and mouth), cryptococcosis, Cryptosporidium infection (cryptosporidiosis), Culex mosquito infection (West Nile fever virus carrier), cyclosporiasis (Cyclospora infection), cysticercosis (neurocysticercosis), dengue infection, infection dogs and cats), ge virus orragicheskoy Ebola fever, encephalitis, infections Entamoeba coli, Entamoeba dispar infection, Entamoeba hartmanni infections, Entamoeba histo |